NO972065L - Lagringsstabil vannopplösning for infusjon inneholdende en trombininhibitor - Google Patents

Lagringsstabil vannopplösning for infusjon inneholdende en trombininhibitor

Info

Publication number
NO972065L
NO972065L NO972065A NO972065A NO972065L NO 972065 L NO972065 L NO 972065L NO 972065 A NO972065 A NO 972065A NO 972065 A NO972065 A NO 972065A NO 972065 L NO972065 L NO 972065L
Authority
NO
Norway
Prior art keywords
pct
storage stable
thrombin inhibitor
water solution
stable water
Prior art date
Application number
NO972065A
Other languages
English (en)
Other versions
NO322048B1 (no
NO972065D0 (no
Inventor
Ulla Stjernfelt
Mats Sundgren
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO972065L publication Critical patent/NO972065L/no
Publication of NO972065D0 publication Critical patent/NO972065D0/no
Publication of NO322048B1 publication Critical patent/NO322048B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19972065A 1994-11-08 1997-05-05 Lagringsstabil vannopplosning for infusjon inneholdende en trombininhibitor, fremgangsmate for fremstilling av slik vannopplosning og anvendelse derav. NO322048B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9403831A SE504185C2 (sv) 1994-11-08 1994-11-08 Lagringsstabil vattenlösning för infusion av trombininhibitorer
PCT/SE1995/001228 WO1996014084A1 (en) 1994-11-08 1995-10-19 A storage stable water solution for infusion containing a thrombin inhibitor

Publications (3)

Publication Number Publication Date
NO972065L true NO972065L (no) 1997-05-05
NO972065D0 NO972065D0 (no) 1997-05-05
NO322048B1 NO322048B1 (no) 2006-08-07

Family

ID=20395892

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972065A NO322048B1 (no) 1994-11-08 1997-05-05 Lagringsstabil vannopplosning for infusjon inneholdende en trombininhibitor, fremgangsmate for fremstilling av slik vannopplosning og anvendelse derav.

Country Status (31)

Country Link
US (1) US5830865A (no)
EP (1) EP0789585B1 (no)
JP (1) JPH10508598A (no)
KR (1) KR100416677B1 (no)
CN (1) CN1090508C (no)
AT (1) ATE205399T1 (no)
AU (1) AU695719B2 (no)
BR (1) BR9509634A (no)
CA (1) CA2203396A1 (no)
CZ (1) CZ287256B6 (no)
DE (1) DE69522702T2 (no)
DK (1) DK0789585T3 (no)
EE (1) EE9700218A (no)
ES (1) ES2163528T3 (no)
FI (1) FI971949A7 (no)
HU (1) HU217073B (no)
IL (1) IL115879A (no)
IS (1) IS4468A (no)
MX (1) MX9703339A (no)
MY (1) MY112593A (no)
NO (1) NO322048B1 (no)
NZ (1) NZ295492A (no)
PL (1) PL320342A1 (no)
PT (1) PT789585E (no)
RU (1) RU2164803C2 (no)
SE (1) SE504185C2 (no)
SK (1) SK53597A3 (no)
TR (1) TR199501391A2 (no)
TW (1) TW407057B (no)
WO (1) WO1996014084A1 (no)
ZA (1) ZA959377B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984627B1 (en) * 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
AR005245A1 (es) 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
SE9802974D0 (sv) 1998-09-03 1998-09-03 Astra Ab New crystalline forms
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
US7345093B2 (en) * 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
CA2781529C (en) 2009-09-23 2017-10-24 Indu Javeri Methods for the preparation of liposomes comprising docetaxel
MX2021008557A (es) * 2021-01-13 2021-11-17 Grupo Ion Biotech S A P I De C V Sistema de suministro de ionoforos quimicos de membrana celular sintetica que comprende composiciones de ligandos hexa-acuaticos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2096415C1 (ru) * 1991-09-30 1997-11-20 Дзе Дюпон Мерк Фармасьютикал Компани Циклические пептиды или их фармацевтически приемлемые соли, фармацевтическая композиция
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5466131A (en) * 1994-03-22 1995-11-14 Micropump Corporation Multiple-chamber gear pump with hydraulically connected chambers

Also Published As

Publication number Publication date
AU695719B2 (en) 1998-08-20
HUT77560A (hu) 1998-06-29
CZ129497A3 (cs) 1998-02-18
SK53597A3 (en) 1998-07-08
MY112593A (en) 2001-07-31
CN1162921A (zh) 1997-10-22
TW407057B (en) 2000-10-01
CZ287256B6 (en) 2000-10-11
DE69522702T2 (de) 2002-07-11
IS4468A (is) 1997-04-21
WO1996014084A1 (en) 1996-05-17
CA2203396A1 (en) 1996-05-17
SE504185C2 (sv) 1996-12-02
PL320342A1 (en) 1997-09-29
JPH10508598A (ja) 1998-08-25
SE9403831D0 (sv) 1994-11-08
AU3884695A (en) 1996-05-31
IL115879A0 (en) 1996-01-31
DE69522702D1 (de) 2001-10-18
SE9403831L (sv) 1996-05-09
DK0789585T3 (da) 2001-11-12
IL115879A (en) 2001-08-08
FI971949L (fi) 1997-05-07
PT789585E (pt) 2002-01-30
ZA959377B (en) 1996-05-08
FI971949A0 (fi) 1997-05-07
ATE205399T1 (de) 2001-09-15
US5830865A (en) 1998-11-03
NO322048B1 (no) 2006-08-07
KR970706844A (ko) 1997-12-01
NZ295492A (en) 1998-06-26
EP0789585A1 (en) 1997-08-20
ES2163528T3 (es) 2002-02-01
NO972065D0 (no) 1997-05-05
KR100416677B1 (ko) 2004-06-16
EP0789585B1 (en) 2001-09-12
HU217073B (hu) 1999-11-29
CN1090508C (zh) 2002-09-11
RU2164803C2 (ru) 2001-04-10
BR9509634A (pt) 1998-01-06
MX9703339A (es) 1997-07-31
FI971949A7 (fi) 1997-05-07
EE9700218A (et) 1998-02-16
TR199501391A2 (tr) 1996-06-21

Similar Documents

Publication Publication Date Title
ATE177421T1 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
DK0799209T3 (da) Sulfonamider
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
MD1507G2 (ro) Inhibitori, compoziţie farmaceutică pe baza lor şi procedeu de inhibare a HIV proteazei
DE68919358D1 (de) Zusammensetzung zur behandlung der schizophrenie.
ATE309797T1 (de) Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen
NO972128L (no) 2,2-dikloralkankarboksylsyrer, fremgangsmåte for fremstilling av disse, legemiddel inneholdende disse og anvendelse derav for behandling av insulinresistens
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
FI925787A0 (fi) Proteolytiska enzymers sackarinderivatinhibitorer
NO972065D0 (no) Lagringsstabil vannopplösning for infusjon inneholdende en trombininhibitor
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
ATE179164T1 (de) Hiv-proteaseinhibitoren
EP1325918A4 (en) INHIBITORS OF CARDIAC MUSCLE CELL APOPTOSIS AND THERAPEUTIC / PROPHYLACTIC AGENTS AGAINST HEART DISEASE
TH25616A (th) สารละลายในน้ำสำหรับฉีดที่มีความเสถียรในการเก็บซึ่งประกอบด้วยสารยับยั้งธรอมบิน
DE68919301D1 (de) Verwendung eines Prolylendopeptidase-Inhibitors zur Behandlung von AIDS.
ATE252902T1 (de) Verwendung von calciumkanalanantagonisten zur behandlung von herz-, nieren-, magen-und darmkrankheiten sowie bluthochdruck
ATE167055T1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs
TH19245A (th) วิธีป้องกันการสลายของโปรตีนซี